Avidity Biosciences saw the highest growth of 1.99% in patent filings in April and 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Avidity Biosciences’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Avidity Biosciences has been focused on protecting inventions in Israel(IL) with five publications in Q2 2024
The Israel(IL) Patent Office dominates the patent filings and grants with nearly 38% filings and 50% grants. The Israel(IL), United States(US), Australia(AU), and South Korea(KR) patent Office are among the top ten patent offices where Avidity Biosciences is filings its patents. Among the top granted patent authorities, Avidity Biosciences has 50% of its grants in Israel(IL) and 50% in United States(US).
Arrowhead Pharmaceuticals and Ionis Pharmaceuticals could be the strongest competitors for Avidity Biosciences
In terms of grant share, Avidity Biosciences stands in third position among its competitors. Arrowhead Pharmaceuticals and Ionis Pharmaceuticals secured the top positions according to recent patent publication data.
Patents related to rare diseases lead Avidity Biosciences's portfolio
Avidity Biosciences has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Facioscapulohumeral muscular dystrophy (fshd) related patents lead Avidity Biosciences portfolio followed by muscular dystrophy, and muscle atrophy
Avidity Biosciences has highest number of patents in facioscapulohumeral muscular dystrophy (fshd) followed by muscular dystrophy, muscle atrophy, myotonic dystrophy, and congestive heart failure (heart failure). For facioscapulohumeral muscular dystrophy (fshd), nearly 32% of patents were filed and 40% of patents were granted in Q2 2024.
For comprehensive analysis of Avidity Biosciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
